You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • THU0238 A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Spondyloarthritis - treatment
THU0238 A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20151102
Jul 2015300
Aug 2015802
Sep 20152102
Oct 2015400
Nov 20152401
Dec 2015201
Jan 2016501
Feb 2016200
Mar 2016701
Apr 20162500
May 2016700
Jun 2016600
Jul 20161001
Aug 2016500
Sep 2016800
Oct 2016400
Nov 2016100
Dec 2016500
Jan 2017301
Feb 2017503
Mar 2017700
Apr 2017900
May 2017700
Jun 20171001
Jul 2017403
Aug 20171401
Sep 20171002
Oct 2017400
Nov 20171202
Dec 2017200
Jan 20181000
Feb 2018200
Mar 20181000
Apr 2018400
May 20181000
Jun 2018200
Jul 2018801
Aug 2018401
Sep 2018200
Nov 2018200
Dec 2018200
Jan 2019601
Mar 2019201
Apr 2019600
May 2019802
Jul 2019600
Aug 20191200
Oct 2019800
Nov 20192100
Dec 2019500
Jan 20201000
Feb 20201000
Mar 2020402
Apr 2020600
May 2020201
Jun 2020500
Jul 2020600
Aug 2020202
Sep 20201600
Oct 2020400
Nov 2020801
Dec 2020300
Jan 2021400
Feb 2021400
Mar 2021600
Apr 2021800
May 2021300
Jun 2021100
Sep 2021001
Oct 2021400
Nov 20213700
Dec 20211400
Jan 20221201
Feb 2022600
Mar 20222601
Apr 20221300
May 20221801
Jun 2022200
Jul 20222200
Aug 20221200
Sep 2022400
Oct 2022800
Nov 2022900
Dec 20221500
Jan 2023601
Feb 2023700
Mar 2023200
Apr 20231700
May 2023300
Jun 20232000
Jul 20231300
Aug 2023600
Sep 2023500
Oct 2023200
Nov 2023200
Dec 2023700
Jan 20241300
Feb 2024501
Mar 20241400
Total801042